Literature DB >> 2886092

Reversal of parkinsonism by fetal nerve cell transplants in primate brain.

J R Sladek, T J Collier, S N Haber, A Y Deutch, J D Elsworth, R H Roth, D E Redmond.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2886092     DOI: 10.1111/j.1749-6632.1987.tb23706.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

Review 1.  The immunological challenges of cell transplantation for the treatment of Parkinson's disease.

Authors:  Amanda L Piquet; Kala Venkiteswaran; Neena I Marupudi; Matthew Berk; Thyagarajan Subramanian
Journal:  Brain Res Bull       Date:  2012-04-11       Impact factor: 4.077

2.  Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: a comparison with other types of grafts as controls.

Authors:  J R Taylor; J D Elsworth; R H Roth; J R Sladek; T J Collier; D E Redmond
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

3.  Behavioral assessment of the ability of intracerebral embryonic neural tissue grafts to ameliorate the effects of brain damage in marmosets.

Authors:  R M Ridley; H F Baker; L E Annett; S B Dunnett; E M Torres; A Fine
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

Review 4.  Fetal tissue transplantation for patients with Parkinson's disease: a database of published clinical results.

Authors:  E D Clarkson
Journal:  Drugs Aging       Date:  2001       Impact factor: 4.271

5.  Cyclosporin promotes neurorestoration and cell replacement therapy in pre-clinical models of Parkinson's disease.

Authors:  Anna Tamburrino; Madeline J Churchill; Oi W Wan; Yolanda Colino-Sanguino; Rossana Ippolito; Sofie Bergstrand; Daniel A Wolf; Niculin J Herz; Michelle D Sconce; Anders Björklund; Charles K Meshul; Mickael Decressac
Journal:  Acta Neuropathol Commun       Date:  2015-12-14       Impact factor: 7.801

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.